MedTrace Logo

European Union (EU) Post-Market Study on Easyband®

NCT00948246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2014-10-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect additional safety, performance and effectiveness data of the Easyband gastric band medical device in the treatment of morbid obesity in 4 European countries where the device is a CE marked approved product.

Conditions

  • Morbid Obesity

Interventions

DEVICE

Easyband®

The Easyband adjustable gastric band device is implanted laparoscopically around the top of the stomach to create a small pouch. Adjustments to increase or decrease the stoma size are made non-invasively by telemetric connection between an internal and external antenna.

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-10-31
Completion
2011-12-31

Countries

  • Belgium
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00948246 on ClinicalTrials.gov